首页> Pharmacological research> Topical VX-509 attenuates psoriatic inflammation through the STAT3/FABP5 pathway in keratinocytes.

Topical VX-509 attenuates psoriatic inflammation through the STAT3/FABP5 pathway in keratinocytes.

导出 LinkOut

翻译打印收藏纠错

第一作者： Bei,Yan

第一单位： The Department of Dermatology, Xiangya Hospital, Central South University, China; National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, China; Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, China; Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, China.

作者： Bei,Yan ^[1] ; Panpan,Liu ^[1] ; Xiaoqin,Yi ^[1] ; Jie,Li ^[1] ; Nian,Liu ^[1] ; Wu,Zhu ^[1] ; Yehong,Kuang ^[1] ; Xiang,Chen ^[1] ; Cong,Peng ^[2]

作者单位： The Department of Dermatology, Xiangya Hospital, Central South University, China; National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, China; Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, China; Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, China. ^[1] The Department of Dermatology, Xiangya Hospital, Central South University, China; National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, China; Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, China; Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, China. Electronic address: pengcongxy@csu.edu.cn. ^[2]